Applied Biosystems reiterated at neutral by Merrill

Merrill Lynch analyst Darryl Pardi reiterated Applied Biosystems Group at a neutral rating. The company reported second-quarter earnings per share of $0.32, $0.03 above Merrill's estimate and $0.02 better than Wall Street consensus. The analyst raised its 2006 earnings-per-share estimate by $0.03 to $1.18 to reflect the better-than-expected second-quarter results. Shares of the Foster City, Calif., biotechnology company were up 10 cents, or 0.36%, at $27.97 on volume of 1,141,200 shares versus the three-month running average of 1,262,840 shares. (NYSE: ABI)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.